Spots Global Cancer Trial Database for A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors
Official Title: A Phase I/II Study of OBI-3424 in Subjects With Advanced Solid Tumors
Study ID: NCT03592264
Interventions
Study Description
Brief Summary: A first-in-human open-label, Phase I/II study to evaluate the safety, tolerability, MTD/RP2D, PK, and preliminary efficacy of OBI-3424 administered as a single agent.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Scripps Clinic Torrey Pines, La Jolla, California, United States
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
MD Anderson Cancer Center, Houston, Texas, United States
Contact Details
Name: Apostolia Tsimberidou, MD, PHD
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
